| Evaluation of In Vivo Wound Healing Activity of Bacopa monniera on Different Wound Model in Rats S Murthy, MK Gautam, S Goel, V Purohit, H Sharma, RK Goel BioMed research international 2013 (1), 972028, 2013 | 217 | 2013 |
| Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+ Hib) vaccine in comparison with a foreign competitor following primary and … HJ Sharma, S Yadav, SK Lalwani, SV Kapre, SS Jadhav, A Chakravarty, ... Human vaccines 7 (4), 451-457, 2011 | 34 | 2011 |
| Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India HJ Sharma, VS Padbidri, SV Kapre, SS Jadhav, RM Dhere, SS Parekh, ... The Journal of Infection in Developing Countries 5 (12), 874-881, 2011 | 32 | 2011 |
| Sero-surveillance to assess immunity to rubella and assessment of immunogenicity and safety of a single dose of rubella vaccine in school girls H Sharma, S Chowdhari, TR Raina, S Bhardwaj, G Namjoshi, S Parekh Indian Journal of Community Medicine 35 (1), 134-137, 2010 | 30 | 2010 |
| Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin … CA Rentsch, P Bosshard, G Mayor, M Rieken, H Püschel, G Wirth, ... Oncoimmunology 9 (1), 1748981, 2020 | 27 | 2020 |
| A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants H Sharma, S Yadav, S Lalwani, V Gupta, S Kapre, S Jadhav, ... Vaccine 29 (13), 2359-2364, 2011 | 26 | 2011 |
| Antibody persistence of two pentavalent DTwP–HB–Hib vaccines to the age of 15–18 months, and response to the booster dose of quadrivalent DTwP–Hib vaccine H Sharma, S Yadav, S Lalwani, S Kapre, S Jadhav, S Parekh, S Palkar, ... Vaccine 31 (3), 444-447, 2013 | 23 | 2013 |
| Immunization coverage and immunity to diphtheria and tetanus among children in Hyderabad, India MV Murhekar, S Bitragunta, Y Hutin, A Ckakravarty, HJ Sharma, ... Journal of infection 58 (3), 191-196, 2009 | 23 | 2009 |
| An immunogenicity, safety and post-marketing surveillance of a novel adsorbed human diploid cell rabies vaccine (Rabivax®) in Indian subjects MK Sudarshan, S Bhardwaj, BJ Mahendra, H Sharma, TV Sanjay, ... Human vaccines 4 (4), 275-279, 2008 | 23 | 2008 |
| VPM1002 as prophylaxis against severe respiratory tract infections including coronavirus disease 2019 in the elderly: a phase 3 randomized, double-blind, placebo-controlled … AM Blossey, S Brückner, M May, GP Parzmair, H Sharma, U Shaligram, ... Clinical Infectious Diseases 76 (7), 1304-1310, 2023 | 19 | 2023 |
| Screening of cultivars/varieties against mango anthracnose caused by Colletotrichum gloeosporioides RG Bhagwat, BP Mehta, VA Patil, H Sharma Int. J. Environ. Agric. Res 1, 21-23, 2015 | 16 | 2015 |
| Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small … HJ Sharma, VD Patil, SK Lalwani, MV Manglani, L Ravichandran, ... Vaccine 30 (3), 510-516, 2012 | 16 | 2012 |
| No demonstrable association between the Leningrad–Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt HJ Sharma, SA Oun, SS Abou Bakr, SV Kapre, SS Jadhav, RM Dhere, ... Clinical microbiology and infection 16 (4), 347-352, 2010 | 14 | 2010 |
| A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non–muscle-invasive … R Sood, H Sharma, B Sharma, S Parekh, P Pujari, S Shewale Urologic Oncology: Seminars and Original Investigations 38 (5), 433-439, 2020 | 13 | 2020 |
| Vaccines for type 1 diabetes: prevention or reversal? S Desai, S Buchade, S Chitlange, H Sharma, D Bhombe, S Shewale, ... Current diabetes reviews 17 (1), 30-36, 2021 | 11 | 2021 |
| Safety and immunogenicity of single dose of tetanus–diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007 S Bitragunta, MV Murhekar, A Chakravarti, V Verma, GS Namjoshi, ... Vaccine 28 (37), 5934-5938, 2010 | 11 | 2010 |
| Safety and immunogenicity of an indigenously developed Haemophilus influenzae type b conjugate vaccine through various phases of clinical trials HJ Sharma, AS Multani, AK Dutta, SM Joshi, S Malik, S Bhardwaj, ... Human Vaccines 5 (7), 483-487, 2009 | 11 | 2009 |
| Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India … H Sharma, S Parekh, P Pujari, S Shewale, S Desai, N Bhatla, S Joshi, ... The Lancet Oncology 24 (12), 1321-1333, 2023 | 9 | 2023 |
| Sero-surveillance to assess rubella susceptibility and assessment of immunogenicity and reactogenicity of rubella vaccine in Indian girls aged 18-24 years DS Phalgune, RC Yervadekar, HJ Sharma, RM Dhere, SS Parekh, ... Human Vaccines & Immunotherapeutics 10 (10), 2813-2818, 2014 | 7 | 2014 |
| Regulatory Practices in Pharmaceutical Industry H Sharma, S Parekh, S Shewale Pharmaceutical Regulatory Affairs, 2014 | 6 | 2014 |
Sonali PalkarAssociate Professor在 bharatividyapeeth.edu 的电子邮件经过验证
